In situ forming oxygen/ROS-responsive niche-like hydrogel enabling gelation-triggered chemotherapy and inhibition of metastasis

Though the development of the diverse hypoxia-activated prodrugs (HAPs) has made great progresses in the last several decades, current cancer therapy based on HAPs still suffers many obstacles, e.g., poor therapeutic outcome owing to hard deep reaching to hypoxic region, and the occurrence of metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shi-Xiong, Zhang, Ji, Xue, Fengfeng, Liu, Wei, Kuang, Yichen, Gu, Bingxin, Song, Shaoli, Chen, Hangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417960/
https://www.ncbi.nlm.nih.gov/pubmed/36093330
http://dx.doi.org/10.1016/j.bioactmat.2022.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417960/
https://www.ncbi.nlm.nih.gov/pubmed/36093330
http://dx.doi.org/10.1016/j.bioactmat.2022.08.002

Ejemplares similares